Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
14.34
+0.89 (6.62%)
At close: Aug 24, 2026, 4:00 PM EDT
14.61
+0.27 (1.86%)
Pre-market: Aug 25, 2026, 6:03 AM EDT
ARCT Market Cap
ARCT has a market cap or net worth of $407.59 million as of August 25, 2026. Its market cap has decreased by -18.90% in one year.
Market Cap
407.59M
Enterprise Value
239.04M
1-Year Change
-18.90%
Ranking
Category
Stock Price
$14.34
ChartMarket Cap Chart
Since May 22, 2013, ARCT's market cap has increased from $103.00M to $407.59M, an increase of 295.72%. That is a compound annual growth rate of 10.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 407.60M | 133.98% |
| Dec 31, 2025 | 174.20M | -62.11% |
| Dec 31, 2024 | 459.70M | -45.44% |
| Dec 29, 2023 | 842.60M | 87.54% |
| Dec 30, 2022 | 449.30M | -53.95% |
| Dec 31, 2021 | 975.60M | -8.18% |
| Dec 31, 2020 | 1.06B | 546.29% |
| Dec 31, 2019 | 164.40M | 238.97% |
| Dec 31, 2018 | 48.50M | 54.95% |
| Dec 29, 2017 | 31.30M | -45.94% |
| Dec 30, 2016 | 57.90M | -32.75% |
| Dec 31, 2015 | 86.10M | 69.16% |
| Dec 31, 2014 | 50.90M | -79.27% |
| Dec 31, 2013 | 245.50M | 138.35% |
| May 22, 2013 | 103.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 400.37M |
| Fennec Pharmaceuticals | 395.91M |
| Enanta Pharmaceuticals | 392.32M |
| Rocket Pharmaceuticals | 385.31M |
| Upstream Bio | 381.75M |
| Lyell Immunopharma | 380.56M |
| Clinuvel Pharmaceuticals | 376.65M |
| Century Therapeutics | 374.83M |